Beyond established pharmacotherapy, some authors have proposed cannabinoid-modulating “antidotes,” such as the CB1 antagonist rimonabant or cannabidiol, for acute SCRA intoxication, including psychosis, but evidence is preliminary and potential psychiatric risks warrant caution [69]. The gene discussed is CNR1; the disease is psychotic disorder.